Strides Arcolab gets USFDA nod for cancer drug
Quotes

Strides Arcolab gets USFDA nod for cancer drug

Last Updated: Monday, September 3, 2012, 16:14
 
 Comment 0
 
Strides Arcolab gets USFDA nod for cancer drug
New Delhi: Drug firm Strides Arcolab Monday said its subsidiary has received American health regulator's approval to sell Vinorelbine injection, a cancer drug, in the American market.

Onco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab has received final approval from US Food and Drug Administration (USFDA) for Vinorelbine Injection, Strides said in a statement.

"Vinorelbine is part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch," it added.

Vinorelbine is used to treat various types of cancers. It is a chemotherapy drug that works by slowing or stopping cancer cell growth.

Shares of Strides Arcolab were trading at Rs 819.50 on the BSE in late afternoon trade, down 1.21 percent from its previous close.

PTI



First Published: Monday, September 3, 2012, 16:14


Comments


comments powered by Disqus
Renault Kwid
Renault Kwid
Tata GenX Nano
Tata GenX Nano
2015 Indian Roadmaster
2015 Indian Roadmaster
Forbes 2015 Rich List
Forbes 2015 Rich List
Audi TT Coupé
Audi TT Coupé

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved